Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
PLoS Pathog. 2024 Oct 18;20(10):e1012611. doi: 10.1371/journal.ppat.1012611. eCollection 2024 Oct.
Bacillus thuringiensis (Bt) has been successfully used commercially for more than 60 years for biocontrol of insect pests. Since 1996, transgenic plants expressing Bt crystal (Cry) proteins have been used commercially to provide protection against insects that predate on corn and cotton. More recently, Bt Cry proteins that target nematodes have been discovered. One of these, Cry14Ab, has been expressed in transgenic soybean plants and found to provide significant protection against the soybean cyst nematode, Heterodera glycines. However, to date there has been no description of high-level resistance to any Cry14A family protein in nematodes. Here, we describe forward genetic screens to identify such mutants using the nematode Caenorhabditis elegans. Although non-conditional screens failed to identify highly resistant C. elegans, a conditional (temperature-sensitive) genetic screen identified one mutant, bre-6(ye123) (for Bt protein resistant), highly resistant to both Cry14Aa and Cry14Ab. The mutant comes at a high fitness cost, showing significant delays in growth and development and reduced fecundity. bre-6(ye123) hermaphrodites are only weakly resistant to copper intoxication, indicating that the mutant is not highly resistant to all insults. Backcrossing-whole genome sequencing was used to identify the gene mutated in ye123 as the nuclear hormone receptor nhr-31. RNAi, DNA rescue, and CRISPR analyses confirm that resistance to Cry14Aa intoxication in bre-6(ye123) is due to mutation of nhr-31 and was renamed nhr-31(ye123). As predicted for a mutation in this gene, nhr-31(ye123) animals showed significantly reduced expression of most of the subunits of the C. elegans vacuolar ATPase (vATPase). Mutants in the vATPase subunits unc-32 and vha-7 also show resistance to Cry14Aa and/or Cry14Ab. These data demonstrate that nhr-31 and the vATPase play a significant role in the intoxication of C. elegans by Cry14A family proteins, that reduction in vATPase levels result in high resistance to Cry14A family proteins, and that such resistance comes at a high fitness cost. Based on the relative difficulty of finding resistant mutants and the fitness cost associated with the vATPase pathway, our data suggest that transgenic Cry14Ab plants may hold up well to resistance by nematode parasites.
苏云金芽孢杆菌(Bt)已成功商业化使用超过 60 年,用于防治昆虫害虫。自 1996 年以来,表达 Bt 晶体(Cry)蛋白的转基因植物已被商业化用于防治以玉米和棉花为食的昆虫。最近,发现了靶向线虫的 BtCry 蛋白。其中一种,Cry14Ab,已在转基因大豆植物中表达,并发现对大豆胞囊线虫, Heterodera glycines 提供了显著的保护。然而,迄今为止,尚未有关于线虫对任何 Cry14A 家族蛋白产生高水平抗性的描述。在这里,我们使用线虫秀丽隐杆线虫描述了用于鉴定此类突变体的正向遗传筛选。尽管非条件筛选未能鉴定出高度抗线虫的秀丽隐杆线虫,但条件(温度敏感)遗传筛选鉴定出一个突变体,bre-6(ye123)(对 Bt 蛋白具有抗性),对 Cry14Aa 和 Cry14Ab 均具有高度抗性。该突变体代价高昂,表现出生长和发育明显延迟,繁殖力降低。bre-6(ye123)雌雄同体对铜中毒的抵抗力较弱,表明该突变体并非对所有刺激均具有高度抗性。回交-全基因组测序用于鉴定突变体中突变的基因是核激素受体 nhr-31。RNAi、DNA 拯救和 CRISPR 分析证实,bre-6(ye123)对 Cry14Aa 中毒的抗性是由于 nhr-31 的突变引起的,并将其重新命名为 nhr-31(ye123)。正如该基因突变所预测的那样,nhr-31(ye123)动物的大多数秀丽隐杆线虫液泡型 ATP 酶(vATPase)亚基的表达明显降低。unc-32 和 vha-7 等 vATPase 亚基的突变体也对 Cry14Aa 和/或 Cry14Ab 具有抗性。这些数据表明,nhr-31 和 vATPase 在 Cry14A 家族蛋白对秀丽隐杆线虫的中毒中起着重要作用,vATPase 水平的降低导致对 Cry14A 家族蛋白的高度抗性,并且这种抗性代价高昂。基于发现抗性突变体的相对难度和与 vATPase 途径相关的适应性成本,我们的数据表明,转基因 Cry14Ab 植物可能对线虫寄生虫的抗性具有良好的抵抗力。